Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 01, 2005 (Vol. 25, No. 15)

Preparing for a Potential Pandemic

Therapeutic and Vaccine Manufacturers Working to Combat the Avian Flu

  • As the influenza season approaches, health officials remain concerned about the H5N1 strain of avian flu. Humans have no immunity to this strain, which is more virulent than the 1997 version that killed six people in Hong Kong. So far, however, only one human-to-human transmission of the H5N1 virus ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.